Pulmonary Disease, Chronic Obstructive

• GSK Investigational Site — Absecon, New Jersey, United States
• GSK Investigational Site — Charleston, South Carolina, United States
• GSK Investigational Site — Greenville, South Carolina, United States
• GSK Investigational Site — Spartanburg, South Carolina, United States

• GSK Investigational Site — Jasper, Alabama, United States
• GSK Investigational Site — Mobile, Alabama, United States
• GSK Investigational Site — Glendale, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Jasper, Alabama, United States

• Boehringer Ingelheim Investigational Site — Berlin, Germany
• Boehringer Ingelheim Investigational Site — Frankfurt, Germany
• Boehringer Ingelheim Investigational Site — Gauting, Germany
• Boehringer Ingelheim Investigational Site — Großhansdorf, Germany

• GSK Investigational Site — Alkmaar, Netherlands
• GSK Investigational Site — Almelo, Netherlands
• GSK Investigational Site — Amsterdam, Netherlands
• GSK Investigational Site — Amsterdam, Netherlands

• GSK Investigational Site — Grimmenstein, Austria
• GSK Investigational Site — Mödling, Austria
• GSK Investigational Site — Salzburg, Austria
• GSK Investigational Site — Vienna, Austria

• GSK Investigational Site — Fukuoka, Japan

• Altana Pharma/Nycomed Investigational Site — Fullerton, California, United States
• Altana Pharma/Nycomed Investigational Site — Los Angeles, California, United States
• Altana Pharma/Nycomed Investigational Site — Los Angeles, California, United States
• Altana Pharma/Nycomed Investigational Site — Palmdale, California, United States

Not specified

• Seoul National University Hospital — Seoul, South Korea